Reckitt Benckiser Group plc (ETR:3RB)

Market Cap	43.57B
Revenue (ttm)	16.90B
Net Income (ttm)	1.82B
Shares Out	n/a
EPS (ttm)	2.55
PE Ratio	23.92
Forward PE	n/a
Dividend	2.31 (3.62%)
Ex-Dividend Date	n/a

Volume	3,917
Average Volume	9,602
Open	64.04
Previous Close	64.72
Day's Range	63.70 - 64.04
52-Week Range	47.52 - 69.00
Beta	0.12
RSI	61.01
Earnings Date	Mar 6, 2025

About Reckitt Benckiser Group

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet bra...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 1819
• Employees: 40,000
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: 3RB

Financial Performance

In 2023, Reckitt Benckiser Group's revenue was 14.61 billion, an increase of 1.07% compared to the previous year's 14.45 billion. Earnings were 1.64 billion, a decrease of -29.48%.

Financial numbers in GBP